BOSTON--(BUSINESS WIRE)--Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data presented at IDWeek 2025â„¢ in Atlanta, Ga., by researchers ...
Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio’s Metagenomic Sequencing Test for Improving CNS Diagnosis Delve Detect delivers 22 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results